Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · see citing works

Multiplex Genome Engineering Using CRISPR/Cas Systems

Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339 · see citing works

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437 · see citing works

CRISPR-Cas systems for editing, regulating and targeting genomes

Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153 · see citing works

Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769 · see citing works

High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects

Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673 · see citing works

CRISPR/Cas, the Immune System of Bacteria and Archaea

Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,471 · see citing works

RNA-guided editing of bacterial genomes using CRISPR-Cas systems

Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429 · see citing works

Rationally engineered Cas9 nucleases with improved specificity

Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414 · see citing works

Crystal structure of Cas9 in complex with guide RNA and target DNA

Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306 · see citing works

CRISPR–Cas9 Structures and Mechanisms

Jiang, F., & Doudna, J. A. (2017) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-062215-010822 · Cited by 2,029 · see citing works

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · see citing works

High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity

Pattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2673 · Cited by 1,487 · see citing works

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo

Zuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460 · see citing works

Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease

Anders, C., Niewoehner, O., Duerst, A., & Jínek, M. (2014) · Nature · doi:10.1038/nature13579 · Cited by 1,319 · see citing works

Genome-scale CRISPR-Cas9 Knockout and Transcriptional Activation Screening

Joung, J., Konermann, S., Gootenberg, J. S., Abudayyeh, O. O., Platt, R. J., Brigham, M. D., Sanjana, N. E., & Zhang, F. (2017) · Nature Protocols · doi:10.1038/nprot.2017.016 · Cited by 1,243 · see citing works

Enhanced proofreading governs CRISPR-Cas9 targeting accuracy

Chen, J. S., Dagdas, Y. S., Kleinstiver, B. P., Welch, M. M., Sousa, A. A., Harrington, L. B., Sternberg, S. H., Joung, J. K., Yildiz, A., & Doudna, J. A. (2017) · Nature · doi:10.1038/nature24268 · Cited by 1,168 · see citing works

Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells

Hendel, A., Bak, R. O., Clark, J. T., Kennedy, A. B., Ryan, D. E., Roy, S., Steinfeld, I., Lunstad, B. D., Kaiser, R. J., Wilkens, A. B., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3290 · Cited by 1,090 · see citing works

Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification

Guilinger, J. P., Thompson, D. B., & Liu, D. R. (2014) · Nature Biotechnology · doi:10.1038/nbt.2909 · Cited by 836 · see citing works

LNA (Locked Nucleic Acid):  High-Affinity Targeting of Complementary RNA and DNA

Vester, B., & Wengel, J. (2004) · Biochemistry · doi:10.1021/bi0485732 · Cited by 727 · see citing works

Conformational control of DNA target cleavage by CRISPR–Cas9

Sternberg, S. H., LaFrance, B., Kaplan, M., & Doudna, J. A. (2015) · Nature · doi:10.1038/nature15544 · Cited by 627 · see citing works

Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality

Elmén, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki193 · Cited by 563 · see citing works

A Cas9–guide RNA complex preorganized for target DNA recognition

Jiang, F., Zhou, K., Ma, L., Gressel, S., & Doudna, J. A. (2015) · Science · doi:10.1126/science.aab1452 · Cited by 551 · see citing works

A Rapid and General Assay for Monitoring Endogenous Gene Modification

Guschin, D. Y., Waite, A. J., Katibah, G. E., Miller, J. C., Holmes, M. C., & Rebar, E. J. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-753-2_15 · Cited by 500 · see citing works

Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing

Yin, H., Song, C.-Q., Suresh, S., Wu, Q., Walsh, S., Rhym, L. H., Mintzer, E., Bolukbasi, M. F., Zhu, L. J., Kauffman, K., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.4005 · Cited by 499 · see citing works

Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals

Swayze, E. E., Siwkowski, A. M., Wancewicz, E. V., Migawa, M. T., Wyrzykiewicz, T. K., Hung, G., Monia, B. P., & Bennett, A. C. F. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1071 · Cited by 473 · see citing works

CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome

Klann, T. S., Black, J. B., Chellappan, M., Safi, A., Song, L., Hilton, I. B., Crawford, G. E., Reddy, T. E., & Gersbach, C. A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3853 · Cited by 447 · see citing works

Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors

Wang, X., Wang, Y., Wu, X., Wang, J., Wang, Y., Qiu, Z., Chang, T., Huang, H., Lin, R.-J., & Yee, J.-K. (2015) · Nature Biotechnology · doi:10.1038/nbt.3127 · Cited by 442 · see citing works

Cas-analyzer: an online tool for assessing genome editing results using NGS data

Park, J., Lim, K., Kim, J., & Bae, S. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw561 · Cited by 400 · see citing works

Design of LNA probes that improve mismatch discrimination

You, Y. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl175 · Cited by 338 · see citing works

Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity

Tycko, J., Myer, V. E., & Hsu, P. D. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.07.004 · Cited by 304 · see citing works

CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells

Hoban, M. D., Lumaquin, D., Kuo, C. Y., Romero, Z., Long, J., Ho, M., Young, C. S., Mojadidi, M., Fitz-Gibbon, S., Cooper, A. R., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.148 · Cited by 220 · see citing works

A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture

O'Geen, H., Henry, I. M., Bhakta, M. S., Meckler, J. F., & Segal, D. J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv137 · Cited by 219 · see citing works

Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity

Guilinger, J. P., Pattanayak, V., Reyon, D., Tsai, S. Q., Sander, J. D., Joung, J. K., & Liu, D. R. (2014) · Nature Methods · doi:10.1038/nmeth.2845 · Cited by 213 · see citing works

Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq

Kim, D., Kim, S., Kim, S., Park, J., & Kim, J.-S. (2016) · Genome Research · doi:10.1101/gr.199588.115 · Cited by 208 · see citing works

Synthetic CRISPR RNA-Cas9–guided genome editing in human cells

Rahdar, M., McMahon, M. A., Prakash, T. P., Swayze, E. E., Bennett, C. F., & Cleveland, D. W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520883112 · Cited by 183 · see citing works

Design, Synthesis, and Properties of 2‘,4‘-BNA NC : A Bridged Nucleic Acid Analogue

Rahman, S. M. A., Seki, S., Obika, S., Yoshikawa, H., Miyashita, K., & Imanishi, T. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710342q · Cited by 164 · see citing works

2′-O,4′-C-methylene bridged nucleic acid (2′,4′-BNA)

Obika, S., Uneda, T., Sugimoto, T., Nanbu, D., Minami, T., Doi, T., & Imanishi, T. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00325-4 · Cited by 151 · see citing works

Continuous directed evolution of DNA-binding proteins to improve TALEN specificity

Hubbard, B. P., Badran, A. H., Zuris, J. A., Guilinger, J. P., Davis, K. M., Chen, L., Tsai, S. Q., Sander, J. D., Joung, J. K., & Liu, D. R. (2015) · Nature Methods · doi:10.1038/nmeth.3515 · Cited by 121 · see citing works

Structural roles of guide RNAs in the nuclease activity of Cas9 endonuclease

Lim, Y., Bak, S. Y., Sung, K., Jeong, E., Lee, S. H., Kim, J., Bae, S., & Kim, S. K. (2016) · Nature Communications · doi:10.1038/ncomms13350 · Cited by 115 · see citing works

How specific is CRISPR/Cas9 really?

O’Geen, H., Yu, A. S., & Segal, D. J. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2015.10.001 · Cited by 108 · see citing works

Hybridization Kinetics Explains CRISPR-Cas Off-Targeting Rules

Klein, M., Eslami-Mossallam, B., Arroyo, D. G., & Depken, M. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.045 · Cited by 107 · see citing works

Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders

Christie, K. A., Courtney, D., DeDionisio, L., Chao-Shern, C., Majumdar, S. D., Mairs, L., Nesbit, M. A., & Moore, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-16279-4 · Cited by 82 · see citing works

CRISPR-Cas9 cleavage efficiency correlates strongly with target-sgRNA folding stability: from physical mechanism to off-target assessment

Xu, X., Duan, D., & Chen, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-00180-1 · Cited by 78 · see citing works

Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system

Cheong, T.-C., Compagno, M., & Chiarle, R. (2016) · Nature Communications · doi:10.1038/ncomms10934 · Cited by 71 · see citing works

Mapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease

Rueda, F. O., Biśta, M., Newton, M. D., Goeppert, A. U., Cuomo, M. E., Gordon, E., Kroener, F., Read, J. A., Wrigley, J. D. J., Rueda, D., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01732-9 · Cited by 69 · see citing works

Solution Structure of an Intramolecular Pyrimidine−Purine−Pyrimidine Triplex Containing an RNA Third Strand

Gotfredsen, C. H., Schultze, P., & Feigon, J. F. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973221m · Cited by 46 · see citing works

CRISPR-DAV: CRISPR NGS data analysis and visualization pipeline

Wang, X., Tilford, C. A., Neuhaus, I., Mintier, G. A., Guo, Q. J., Feder, J. N., & Kirov, S. A. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx518 · Cited by 45 · see citing works

In Vitro Reconstitution and Crystallization of Cas9 Endonuclease Bound to a Guide RNA and a DNA Target

Anders, C., Niewoehner, O., & Jínek, M. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2015.02.008 · Cited by 30 · see citing works

BNANC Gapmers Revert Splicing and Reduce RNA Foci with Low Toxicity in Myotonic Dystrophy Cells

Manning, K. S., Rao, A. N., Castro, M., & Cooper, T. A. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00416 · Cited by 20 · see citing works

RNA-based therapeutics: an overview and prospectus

Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05075-2 · Cited by 658 · see citing works

Off-target effects in CRISPR/Cas9 gene editing

Guo, C., Ma, X., Gao, F., & Guo, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1143157 · Cited by 625 · see citing works

CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors

Wang, D., Zhang, F., & Gao, G. (2020) · Cell · doi:10.1016/j.cell.2020.03.023 · Cited by 526 · see citing works

Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing

Naeem, M., Majeed, S., Hoque, M. Z., & Ahmad, I. (2020) · Cells · doi:10.3390/cells9071608 · Cited by 457 · see citing works

Recent progress in non-native nucleic acid modifications

McKenzie, L. K., El-Khoury, R., Thorpe, J. D., Damha, M. J., & Hollenstein, M. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01430c · Cited by 300 · see citing works

Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing

Tao, J., Bauer, D. E., & Chiarle, R. (2023) · Nature Communications · doi:10.1038/s41467-023-35886-6 · Cited by 215 · see citing works

Structural basis for Cas9 off-target activity

Pacesa, M., Lin, C.-H., Cléry, A., Saha, A., Arantes, P. R., Bargsten, K., Irby, M. J., Allain, F. H.-T., Palermo, G., Cameron, P., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.026 · Cited by 198 · see citing works

Development of CRISPR-Cas systems for genome editing and beyond

Zhang, F. (2019) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583519000052 · Cited by 185 · see citing works

Chemically Modified Platforms for Better RNA Therapeutics

Shi, Y., Zhen, X., Zhang, Y., Li, Y., Koo, S., Saiding, Q., Kong, N., Liu, G., Chen, W., & Tao, W. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00611 · Cited by 184 · see citing works

Evaluating and enhancing target specificity of gene-editing nucleases and deaminases

Kim, D., Luk, K., Wolfe, S. A., & Kim, J.-S. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111730 · Cited by 171 · see citing works

CRISPR-Cas9-mediated homology-directed repair for precise gene editing

Liao, H., Wu, J., VanDusen, N. J., Li, Y., & Zheng, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102344 · Cited by 181 · see citing works

Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing

Han, H. A., Pang, J. K. S., & Soh, B.-S. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01893-z · Cited by 143 · see citing works

CRISPR/dCas9-Based Systems: Mechanisms and Applications in Plant Sciences

Karlson, C. K. S., Noor, S. N. M., Nolte, N., & Tan, B. C. (2021) · Plants · doi:10.3390/plants10102055 · Cited by 126 · see citing works

CRISPR Modeling and Correction of Cardiovascular Disease

Liu, N., & Olson, E. N. (2022) · Circulation Research · doi:10.1161/circresaha.122.320496 · Cited by 118 · see citing works

Improving CRISPR Genome Editing by Engineering Guide RNAs

Moon, S. B., Kim, D. Y., Kim, J., Kim, J., & Kim, Y.-S. (2019) · Trends in biotechnology · doi:10.1016/j.tibtech.2019.01.009 · Cited by 104 · see citing works

Comparison of the Feasibility, Efficiency, and Safety of Genome Editing Technologies

Castro, N. G. G., Bjelic, J., Malhotra, G., Huang, C., & Alsaffar, S. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910355 · Cited by 107 · see citing works

Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach

Haghighi, E., Abolmaali, S. S., Dehshahri, A., Shaegh, S. A. M., Azarpira, N., & Tamaddon, A. M. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02972-w · Cited by 111 · see citing works

Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments

Kimberland, M. L., Hou, W., Alfonso-Pecchio, A. R., Wilson, S. P., Rao, Y., Zhang, S., & Lu, Q. (2018) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2018.08.007 · Cited by 96 · see citing works

Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems

Filippova, J. A., Matveeva, A. M., Zhuravlev, E. S., & Stepanov, G. A. (2019) · Biochimie · doi:10.1016/j.biochi.2019.09.003 · Cited by 95 · see citing works

Conditional control of RNA-guided nucleic acid cleavage and gene editing

Wang, S., Wu, L., Huang, H., Xiong, W., Liu, J., Wei, L., Yin, P., Tian, T., & Zhou, X. (2020) · Nature Communications · doi:10.1038/s41467-019-13765-3 · Cited by 96 · see citing works

Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing

Chen, Q., Zhang, Y., & Yin, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.014 · Cited by 97 · see citing works

Chemical Synthesis and Biological Application of Modified Oligonucleotides

Glazier, D. A., Liao, J., Roberts, B. L., Li, X., Yang, K., Stevens, C. M., & Tang, W. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00060 · Cited by 91 · see citing works

RNA chemistry and therapeutics

Wang, S., Weissman, D., & Dong, Y. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01237-x · Cited by 98 · see citing works

CRISPR/Cas9 Landscape: Current State and Future Perspectives

Tyumentsev, A. I., Tyumentsev, A. I., & Акимкин, В. Г. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216077 · Cited by 95 · see citing works

Chemical Modifications of CRISPR RNAs to Improve Gene-Editing Activity and Specificity

Rozners, E. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c02633 · Cited by 85 · see citing works

Using Synthetically Engineered Guide RNAs to Enhance CRISPR Genome Editing Systems in Mammalian Cells

Allen, D. G., Rosenberg, M., & Hendel, A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.617910 · Cited by 82 · see citing works

Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics

Lopes, R., & Prasad, M. K. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1339189 · Cited by 82 · see citing works

2′- O -Methyl modified guide RNA promotes the single nucleotide polymorphism (SNP) discrimination ability of CRISPR–Cas12a systems

Ke, Y., Ghalandari, B., Huang, S., Li, S., Huang, C., Zhi, X., Cui, D., & Ding, X. (2022) · Chemical Science · doi:10.1039/d1sc06832f · Cited by 78 · see citing works

CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer

Azangou‐Khyavy, M., Ghasemi, M., Khanali, J., Boroomand-Saboor, M., Jamalkhah, M., Soleimani, M., & Kiani, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02062 · Cited by 77 · see citing works

Precise genome-editing in human diseases: mechanisms, strategies and applications

Zheng, Y., Li, Y., Zhou, K., Li, T., VanDusen, N. J., & Hua, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01750-2 · Cited by 80 · see citing works

Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine

Azeez, S. S., Hamad, R. S., Hamad, B., Shekha, M. S., & Bergsten, P. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1509924 · Cited by 84 · see citing works

Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells

Donohoue, P. D., Pacesa, M., Lau, E., Vidal, B., Irby, M. J., Nyer, D. B., Rotstein, T., Banh, L., Toh, M. S., Gibson, J., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.035 · Cited by 69 · see citing works

Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells

Méndez-Mancilla, A., Wessels, H.-H., Legut, M., Kadina, A., Mabuchi, M., Walker, J., Robb, G. B., Holden, K., & Sanjana, N. E. (2022) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.07.011 · Cited by 68 · see citing works

Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA

Zhang, Y., Ling, X., Su, X., Zhang, S., 王, J. 璟. W., Zhang, P., Feng, W., Zhu, Y. Y., Liu, T., & Tang, X. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202009890 · Cited by 67 · see citing works

CRISPR/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges

Demirci, S., Leonard, A. K., Haro‐Mora, J. J., Uchida, N., & Tisdale, J. F. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_331 · Cited by 67 · see citing works

Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering

Huang, X., Yang, D., Zhang, J., Xu, J., & Chen, Y. E. (2022) · Cells · doi:10.3390/cells11142186 · Cited by 65 · see citing works

Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing

Li, J., Hong, S., Chen, W., Zuo, E., & Yang, H. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.002 · Cited by 63 · see citing works

An artificial triazole backbone linkage provides a split-and-click strategy to bioactive chemically modified CRISPR sgRNA

Taemaitree, L., Shivalingam, A., El-Sagheer, A. H., & Brown, T. P. (2019) · Nature Communications · doi:10.1038/s41467-019-09600-4 · Cited by 61 · see citing works

Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity

O’Reilly, D., Kartje, Z. J., Ageely, E. A., Malek-Adamian, E., Habibian, M., Schofield, A., Barkau, C. L., Rohilla, K. J., DeRossett, L. B., Weigle, A. T., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1214 · Cited by 61 · see citing works

Cas9 deactivation with photocleavable guide RNAs

Zou, R. S., Liu, Y., Wu, B., & Ha, T. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.02.007 · Cited by 60 · see citing works

Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems

Zheng, N., Li, L., & Wang, X. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.34 · Cited by 56 · see citing works

Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing

Liu, R., Liang, L., Freed, E. F., & Gill, R. T. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.07.005 · Cited by 56 · see citing works

A Conformational Restriction Strategy for the Control of CRISPR/Cas Gene Editing with Photoactivatable Guide RNAs**

Sun, Y., Chen, W., Liu, J., Li, J., Zhang, Y., Cai, W., Liu, L., Tang, X., Hou, J., Wang, M., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202212413 · Cited by 55 · see citing works

Regulation of the CRISPR-Cas12a system by methylation and demethylation of guide RNA

Hu, Z., Sun, A., Yang, J., Naz, G., Sun, G., Li, Z., Liu, J., Zhang, S., & Zhang, X. (2023) · Chemical Science · doi:10.1039/d3sc00629h · Cited by 55 · see citing works

Chemical engineering of CRISPR–Cas systems for therapeutic application

Barber, H. M., Pater, A. A., Gagnon, K. T., Damha, M. J., & O’Reilly, D. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01086-0 · Cited by 55 · see citing works

How to create state-of-the-art genetic model systems: strategies for optimal CRISPR-mediated genome editing

Bollen, Y., Post, J. B., Koo, B., & Snippert, H. J. G. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky571 · Cited by 52 · see citing works

Guide RNAs containing universal bases enable Cas9/Cas12a recognition of polymorphic sequences

Krysler, A. R., Cromwell, C. R., Tu, T., Jovel, J., & Hubbard, B. P. (2022) · Nature Communications · doi:10.1038/s41467-022-29202-x · Cited by 48 · see citing works

Specificity of oligonucleotide gene therapy (OGT) agents

Nedorezova, D. D., Dubovichenko, M. V., Belyaeva, E. P., Grigorieva, E. D., Peresadina, A. V., & Kolpashchikov, D. M. (2022) · Theranostics · doi:10.7150/thno.77830 · Cited by 48 · see citing works

CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering

Lone, B. A., Karna, S. K. L., Ahmad, F., Shahi, N., & Pokharel, Y. R. (2018) · Genetics Research International · doi:10.1155/2018/3797214 · Cited by 48 · see citing works

Allosteric regulation of CRISPR-Cas9 for DNA-targeting and cleavage

Zuo, Z., & Liu, J. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.013 · Cited by 48 · see citing works

Single molecule analysis of effects of non-canonical guide RNAs and specificity-enhancing mutations on Cas9-induced DNA unwinding

Okafor, I. C., Singh, D., Wang, Y., Jung, M., Wang, H., Mallon, J. P., Bailey, S., Lee, J. K., & Ha, T. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1058 · Cited by 44 · see citing works

Natural, modified and conjugated carbohydrates in nucleic acids

Dhara, D., Mulard, L. A., & Hollenstein, M. (2025) · Chemical Society Reviews · doi:10.1039/d4cs00799a · Cited by 44 · see citing works

Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control

Brown, W., Zhou, W., & Deiters, A. (2020) · ChemBioChem · doi:10.1002/cbic.202000423 · Cited by 41 · see citing works

Target Specificity of Cas9 Nuclease via DNA Rearrangement Regulated by the REC2 Domain

Sung, K., Park, J., Kim, Y.-G., Lee, N. K., & Kim, S. K. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b03102 · Cited by 41 · see citing works

CRISPR RNA-guided autonomous delivery of Cas9

Wilkinson, R. A., Martin, C. D., Nemudryi, A. A., & Wiedenheft, B. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0173-y · Cited by 42 · see citing works

Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles

Ageely, E. A., Chilamkurthy, R., Jana, S. K., Abdullahu, L., O’Reilly, D., Jensik, P. J., Damha, M. J., & Gagnon, K. T. (2021) · Nature Communications · doi:10.1038/s41467-021-26989-z · Cited by 39 · see citing works

Paving the way towards precise and safe CRISPR genome editing

Śledziński, P., Dabrowska, M., Nowaczyk, M., & Olejniczak, M. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107737 · Cited by 41 · see citing works

CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: from bench to clinics

Tiwari, P. K., Ko, T.-H., Dubey, R., Chouhan, M., Tsai, L.-W., Singh, H. N., Chaubey, K. K., Dayal, D., Chiang, C., & Kumar, S. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1214489 · Cited by 41 · see citing works

CRISPR techniques and potential for the detection and discrimination of SARS-CoV-2 variants of concern

Xiao, H., Hu, J., Huang, C., Feng, W., Liu, Y., Kumblathan, T., Tao, J., Xu, J., Le, X. C., & Zhang, H. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117000 · Cited by 38 · see citing works

CRISPR/Cas9 gene editing therapies for cystic fibrosis

Graham, C., & Hart, S. L. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1869208 · Cited by 38 · see citing works

Exploring Parkinson-associated kinases for CRISPR/Cas9-based gene editing: beyond alpha-synuclein

Mansour, H. M., & El-Khatib, A. S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102114 · Cited by 36 · see citing works

Matrix metalloproteinase‐2 mediates ribosomal RNA transcription by cleaving nucleolar histones

Ali, M. A., Garcia‐Vilas, J. A., Cromwell, C. R., Hubbard, B. P., Hendzel, M. J., & Schulz, R. (2021) · FEBS Journal · doi:10.1111/febs.16061 · Cited by 36 · see citing works

Optimizing CRISPR/Cas9 precision: Mitigating off-target effects for safe integration with photodynamic and stem cell therapies in cancer treatment

Merlin, J. P. J., & Abrahamse, H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117516 · Cited by 35 · see citing works

Recent advances in CRISPR-based single-nucleotide fidelity diagnostics

Kohabir, K. A. V., Sistermans, E. A., & Wolthuis, R. M. F. (2025) · Communications Medicine · doi:10.1038/s43856-025-00933-4 · Cited by 39 · see citing works

Emerging Gene Therapeutics for Epidermolysis Bullosa under Development

Bischof, J., Hierl, M., & Koller, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042243 · Cited by 35 · see citing works

Iterative crRNA design and a PAM-free strategy enabled an ultra-specific RPA-CRISPR/Cas12a detection platform

Mao, X., Xu, J., Jiang, J., Li, Q., Yao, P., Jiang, J., Gong, L., Dong, Y., Tu, B., Wang, R., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07173-7 · Cited by 33 · see citing works

Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair

van de Vrugt, H. J., Harmsen, T., Riepsaame, J., Alexantya, G., van Mil, S. E., de Vries, Y., Ali, R. B., Huijbers, I. J., Dorsman, J. C., Wolthuis, R. M. F., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36506-w · Cited by 31 · see citing works

Applications of CRISPR/Cas genome editing in economically important fruit crops: recent advances and future directions

Ma, Z., Ma, L., & Zhou, J. (2023) · Molecular Horticulture · doi:10.1186/s43897-023-00049-0 · Cited by 36 · see citing works

Development of aptamer-based inhibitors for CRISPR/Cas system

Zhao, J. C., Inomata, R., Kato, Y., & Miyagishi, M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa865 · Cited by 31 · see citing works

Current advances in overcoming obstacles of CRISPR/Cas9 off-target genome editing

Aquino‐Jarquín, G. (2021) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.08.002 · Cited by 32 · see citing works

Bridged Nucleic Acids Reloaded

Soler‐Bistué, A., Zorreguieta, Á., & Tolmasky, M. E. (2019) · Molecules · doi:10.3390/molecules24122297 · Cited by 31 · see citing works

Harnessing noncanonical crRNA for highly efficient genome editing

Xun, G., Zhu, Z., Singh, N., Lu, J., Jain, P., & Zhao, H. (2024) · Nature Communications · doi:10.1038/s41467-024-48012-x · Cited by 30 · see citing works

Controlling CRISPR‐Cas9 by guide RNA engineering

Hu, L., Li, Y., Wang, J., Zhao, Y., & Wang, Y. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1731 · Cited by 29 · see citing works

Improving Stability and Specificity of CRISPR/Cas9 System by Selective Modification of Guide RNAs with 2′-fluoro and Locked Nucleic Acid Nucleotides

Sakovina, L., Vokhtantsev, I. P., Vorobyeva, M., Vorobjev, P., & Новопашина, Д. С. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113460 · Cited by 29 · see citing works

Engineering guide RNA to reduce the off-target effects of CRISPR

Wu, J., & Yin, H. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.003 · Cited by 27 · see citing works

CrRNA Conformation-Engineered CRISPR-Cas12a System for Robust and Ultrasensitive Nucleic Acid Detection

Li, Y., Hu, Q., Bai, M., Qing, M., & Bai, L. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c06107 · Cited by 26 · see citing works

Bacteriophage λ exonuclease and a 5′-phosphorylated DNA guide allow PAM-independent targeting of double-stranded nucleic acids

Fu, S., Li, J., Chen, J., Zhang, L., Liu, J., Liu, H., & Su, X. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02388-9 · Cited by 25 · see citing works

CRISPR/Cas technologies for cancer drug discovery and treatment

Wang, K. C., Zheng, T., & Hubbard, B. P. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2025.02.009 · Cited by 25 · see citing works

High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus–Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells

Allen, D. G., Weiss, L. E., Saguy, A., Rosenberg, M., Iancu, O., Matalon, O., Lee, C. M., Beider, K., Nagler, A., Shechtman, Y., et al. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0128 · Cited by 24 · see citing works

Lipid phosphate phosphatase-2 promotes tumor growth through increased c-Myc expression

Tang, X., Cromwell, C. R., Liu, R., Godbout, R., Hubbard, B. P., McMullen, T. P. W., & Brindley, D. N. (2022) · Theranostics · doi:10.7150/thno.66230 · Cited by 23 · see citing works

The advancements, challenges, and future implications of the CRISPR/Cas9 system in swine research

Zhang, J., Khazalwa, E. M., Abkallo, H. M., Zhou, Y., Nie, X., Ruan, J., Zhao, C., Wang, J., Xu, J., Li, X., et al. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.03.015 · Cited by 25 · see citing works

From DNA break repair pathways to CRISPR/Cas-mediated gene knock-in methods

Bazaz, M. R., & Dehghani, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120409 · Cited by 22 · see citing works

Acceleration of cancer science with genome editing and related technologies

Sakuma, T., & Yamamoto, T. (2018) · Cancer Science · doi:10.1111/cas.13832 · Cited by 23 · see citing works

CRISPR‐Cas9: A cornerstone for the evolution of precision medicine

Razzouk, S. (2018) · Annals of Human Genetics · doi:10.1111/ahg.12271 · Cited by 22 · see citing works

Highly efficient and safe genome editing by CRISPR-Cas12a using CRISPR RNA with a ribosyl-2′-O-methylated uridinylate-rich 3′-overhang in mouse zygotes

Ha, D.-I., Lee, J. M., Lee, N., Kim, D., Ko, J., & Kim, Y.-S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00521-7 · Cited by 21 · see citing works

Review, analysis, and optimization of the CRISPR Streptococcus pyogenes Cas9 system

Wang, G., & Li, J. (2021) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2021.100080 · Cited by 22 · see citing works

Engineering nucleic acid chemistry for precise and controllable CRISPR/Cas9 genome editing

Cai, W., & Wang, M. (2019) · 中国科学通报：英文版 · doi:10.1016/j.scib.2019.07.035 · Cited by 21 · see citing works

Expanding the Potential of Mammalian Genome Engineering via Targeted DNA Integration

Zhang, M., Yang, C., Tasan, I., & Zhao, H. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00576 · Cited by 20 · see citing works

Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA

Zhang, Y., Ling, X., Su, X., Zhang, S., Wang, J., Zhang, P., Feng, W., Zhu, Y. Y., Liu, T., & Tang, X. (2020) · Angewandte Chemie · doi:10.1002/ange.202009890 · Cited by 21 · see citing works

Unlocking the Potential of Chemically Modified Nucleic Acid Therapeutics

Gao, J., Nutan, B., Gargouri, D., Pisal, N. D., Do, V., Zubair, M., Alanzi, H., Wang, H., Lee, D., Joshi, N., et al. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400231 · Cited by 20 · see citing works

Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies

Papizan, J. B., Porter, S. N., Sharma, A., & Pruett‐Miller, S. M. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20200096 · Cited by 19 · see citing works

Tripeptide IRW Upregulates NAMPT Protein Levels in Cells and Obese C57BL/6J Mice

Bhullar, K. S., Son, M., Kerek, E. M., Cromwell, C. R., Wingert, B. M., Wu, K., Jovel, J., Camacho, C. J., Hubbard, B. P., & Wu, J. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07831 · Cited by 19 · see citing works

Thermophilic Nucleic Acid Polymerases and Their Application in Xenobiology

Wang, G., Du, Y., Ma, X., Ye, F., Qin, Y., Wang, Y., Xiang, Y., Tao, R. X., & Chen, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314969 · Cited by 19 · see citing works

Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo

Zhang, H., Kelly, K. L., Lee, J. L. C., Echeverria, D., Cooper, D., Panwala, R., Amrani, N., Chen, Z., Gaston, N., Wagh, A. A., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1125 · Cited by 19 · see citing works

Reducing CRISPR-Cas9 off-target effects by optically controlled chemical modifications of guide RNA

Qi, Q., Liu, X., Xiong, W., Zhang, K., Shen, W., Zhang, Y., Xu, X., Zhong, C., Zhang, Y., Tian, T., et al. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.09.006 · Cited by 18 · see citing works

Introduction and History of the Chemistry of Nucleic Acids Therapeutics

Gait, M. J., & Agrawal, S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2010-6_1 · Cited by 17 · see citing works

Synthesis and biophysical properties of carbamate-locked nucleic acid (LNA) oligonucleotides with potential antisense applications

Thorpe, C., Epple, S., Woods, B., El-Sagheer, A. H., & Brown, T. P. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob00691e · Cited by 17 · see citing works

CRISPR, animals, and FDA oversight: Building a path to success

Epstein, L. R., Lee, S. S., Miller, M. F., & Lombardi, H. A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004831117 · Cited by 17 · see citing works

Quantitative assessment of engineered Cas9 variants for target specificity enhancement by single-molecule reaction pathway analysis

Bak, S. Y., Jung, Y., Park, J., Sung, K., Jang, H., Bae, S., & Kim, S. K. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab858 · Cited by 17 · see citing works

Viral and nonviral nanocarriers for in vivo CRISPR-based gene editing

Guo, Z., Zhu, A. T., Fang, R. H., & Zhang, L. (2024) · Nano Research · doi:10.1007/s12274-024-6748-5 · Cited by 17 · see citing works

Tailoring CRISPR/Cas specificity using chemically modified guide RNAs

Cromwell, C. R. (2022) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-6kv4-qp74

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · see citing works

Improving CRISPR-Cas nuclease specificity using truncated guide

Joung, J. K. (2016)

Rationally engineered Cas9 nucleases with improved specificity

Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414 · see citing works

Improving Stability and Specificity of CRISPR/Cas9 System by Selective Modification of Guide RNAs with 2′-fluoro and Locked Nucleic Acid Nucleotides

Sakovina, L., Vokhtantsev, I. P., Vorobyeva, M., Vorobjev, P., & Новопашина, Д. С. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113460 · Cited by 29 · see citing works